...
BTXSMALL

BlackRock Technology and Private Equity Term Trust

HealthcareBiotechnology
$6.62
$0.00(+0.99%)
52W$5.10
$7.50
Updated Mar 5, 12:00 AM
RSI47
RS Rating40/99
Beta1.16
Volatility28%
F-Score3/9
Mkt Cap$773M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

BlackRock Technology and Private Equity Term Trust is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 40), showing significant lag compared to the market leaders. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
40
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.16
vs S&P 500
ABOVE MKT
52W Position
63%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$6.68
50 SMA > 100 SMA$6.69
100 SMA > 150 SMA$6.82
150 SMA > 200 SMA$6.90

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.58+0.61%ABOVE
50 SMA$6.68-0.88%BELOW
100 SMA$6.69-1.11%BELOW
150 SMA$6.82-2.94%BELOW
200 SMA$6.90-4.06%BELOW

Price Performance

1D+1.0%
1W+0.3%
1M+5.4%
3M-2.2%
6M-5.7%
YTD-1.0%
1Y-5.3%
3Y-4.8%
52-Week Trading Range63% from low
$6.62
52W Low$5.10
52W High$7.50

Technical Indicators

RSI (14)NEUTRAL
47.3
305070
VCP ScoreCOOL
5/10
Base depth: 12.5%

Risk Profile

Beta
1.16
52W Vol
28%
ATR
$0.16
Max DD (1Y)
-23%

Volume Analysis

Today
668.6K
50D Avg
907.9K
Vol Ratio
0.74x
Liquidity
ILLIQUID
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR

10 Years:-10.48%
5 Years:-19.85%
3 Years:-4.83%
1 Year:-5.29%

Return on Equity

10Y Avg:-14.7%
5Y Avg:-14.7%
3Y Avg:-14.3%
Last Year:1.9%

Key Metrics

Market Cap$773M
Gross Margin1.0%
Net Margin87.7%
Piotroski F-Score3/9

Frequently Asked Questions

Is BTX in an uptrend right now?

BTX has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is BTX overbought or oversold?

BTX's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is BTX outperforming the market?

BTX has a Relative Strength (RS) Rating of 40 out of 99. BTX is currently lagging the broader market.

Where is BTX in its 52-week range?

BTX is trading at $6.62, which is 88% of its 52-week high ($7.50) and 63% above its 52-week low ($5.10).

How volatile is BTX?

BTX has a Beta of 1.16 and 52-week volatility of 28%. It's more volatile than the S&P 500 - expect bigger swings.